|
|
|
 |
 Congress at a Glance |
|
Scientific Programme
|
|
Satellite Programme
|
|
Maps of the Venue
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
| 09:00-11:05
|
|
S.25:
 Treatment track
Bipolar depression: what are the treatment options? |
|
| Chairs: |
David S. Baldwin, United Kingdom |
| |
Eduard Vieta, Spain |
|
|
|
|
| 09:00 |
|
|
S.25.01
Antidepressants may be useless in bipolar depression
|
|
|
Gary Sachs, USA
|
|
|
|
| 09:25 |
|
|
S.25.02
Lithium and anti-epileptic drugs in the treatment of bipolar depression
|
|
|
Rasmus W. Licht, Denmark
|
|
|
|
| 09:00-11:05
|
|
S.26:
 Clinical research track
Opioid and dopamine systems in impulse control and decision making: neurocognitive insights in substance addiction |
|
| Chairs: |
Alexander Kuzmin, Sweden |
| |
Anne Lingford-Hughes, United Kingdom |
|
|
|
|
| 10:40 |
|
|
S.26.05
Neurocognitive functions in alcohol and heroin dependence
|
|
|
Anna Goudriaan, The Netherlands
|
|
|
|
| 09:00-11:05
|
|
S.27:
 Interface track
Differentiating roles of D3 vs D2 dopamine receptors: significance in the treatment of psychiatric disorders |
|
| Chairs: |
Shitij Kapur, United Kingdom |
| |
Mark J. Millan, France |
|
|
|
|
| 09:00 |
|
|
S.27.01
Interactions of antipsychotics with D3 and D2 receptors: novel molecular insights
|
|
|
Graeme Milligan, United Kingdom
|
|
|
|
| 10:40 |
|
|
S.27.05
Dopamine D3 vs D2 receptors as targets in the modulation and control of drug-seeking behaviour
|
|
|
Mauro Corsi, Italy
|
|
|
|
| 09:00-11:05
|
|
S.28:
 Preclinical track
Advances in the pharmacogenetics of psychotropic drugs |
|
| Chairs: |
Leif Bertilsson, Sweden |
| |
Marion Leboyer, France |
|
|
|
|
| 09:00 |
|
|
S.28.01
Pharmacogenetics in psychiatric disorders: an overview
|
|
|
Leif Bertilsson, Sweden
|
|
|
|
| 09:25 |
|
|
|
| 10:40 |
|
|
S.28.05
Genetic factors in nicotine addiction: implications for neuropsychopharmacology
|
|
|
Marcus Munafò, United Kingdom
|
|
|
|
|
|
|
Treatment
track
Clinical
research track
Interface
track
Preclinical
track
Educational updates
track